Clinical trial Recruiting at 1 site Observational Ages 18 and up

ViTrack continuous non-invasive wrist blood pressure monitoring for surgical patients

Official title: Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device

Run by The University of Texas Health Science Center, Houston · NCT06719518 · Data updated 2026-11-12

This test sees if the ViTrack wrist device can continuously track blood pressure in adults having noncardiac surgery who need an arterial line.

More Blood Pressure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedDecember 17, 2025
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT06719518 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for noncardiac surgery who will have an intra-arterial line, have a palpable wrist pulse, and can provide informed consent are ideal candidates.

Probably not a fit

Patients without a clinical need for arterial monitoring or those with wrist deformity, arteriovenous dialysis shunts, amputations, or large inter-arm blood pressure differences are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares the ViTrack non-invasive wrist device against invasive intra-arterial pressure (IAP) recordings during routine noncardiac surgeries. Participants who have a clinical indication for arterial monitoring will wear the ViTrack device while IAP is recorded, allowing calibration and waveform comparison across a wide, clinically relevant pressure range. The protocol excludes patients with wrist abnormalities, dialysis shunts, or large inter-arm blood pressure differences, and requires a palpable pulse and the ability to consent. Data analysis will quantify agreement, bias, and tracking performance between ViTrack and arterial line measurements under dynamic clinical conditions.

Why it matters

Potential benefit: If successful, ViTrack could provide continuous, accurate blood pressure monitoring without an arterial line, reducing invasiveness and expanding monitoring options.

How similar studies have gone: Other non-invasive continuous blood pressure technologies have shown mixed but promising results, though ViTrack's specific design has limited published outcome data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* scheduled to undergo noncardiac surgery with general or spinal anesthesia
* clinical indication for invasive intra-arterial pressure monitoring
* palpable pulse

Exclusion Criteria:

* difference of greater than 10 mmHg in the left versus right arm oscillometric systolic blood pressure
* Upper extremity arteriovenous hemodialysis shunt
* Upper extremity amputation
* Planned surgical position/draping that precludes access to the wrist
* Wrist distortion or pain from arthritis
* Prior trauma or surgery at the radial artery monitoring site
* Unable to provide informed consent
* Clinical contraindication as determined by the clinical team or study investigators

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.